Compliance Node Overview
The FDA Cybersecurity for Medical Devices guidelines require manufacturers to implement a comprehensive cybersecurity risk management program throughout the device lifecycle. This includes identifying and mitigating risks associated with device vulnerabilities, ensuring secure software updates, and maintaining robust data protection measures. Manufacturers must provide a detailed cybersecurity plan during premarket submissions, including threat modeling and post-market surveillance strategies. Additionally, they are required to establish a process for reporting cybersecurity incidents and vulnerabilities to the FDA. Compliance with these guidelines is essential to safeguard patient safety and maintain the integrity of medical devices in a rapidly evolving digital landscape.
Pillar: Cybersecurity · Authority: U.S. Food and Drug Administration · Version: 1.0.0 · Last updated:
Primary source: https://www.fda.gov/medical-devices/digital-health-center-excellence/cybersecurity-medical-devices
SHA-256 integrity: 278c9a67f9186270e4d04893b158bb3f73f85cf2d6f6de6d04673048a74edebb
Primary Citations — 5 traced to source
- FDA Guidance Document - Content of Premarket Submissions for Management of Cybersecurity in Medical Devices
- FDA Cybersecurity for Medical Devices - Postmarket Management
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
⚠ Important: Human Verification Required
Bidda compliance nodes are reference intelligence, not legal advice. Every node must be reviewed by a qualified compliance professional or legal counsel before implementation in any enterprise workflow, regulated system, or compliance programme. See bidda.com/disclaimer for full terms.